Anna Barbro Sætersdal

688 total citations
7 papers, 284 citations indexed

About

Anna Barbro Sætersdal is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Anna Barbro Sætersdal has authored 7 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Anna Barbro Sætersdal's work include Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Anna Barbro Sætersdal is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Anna Barbro Sætersdal collaborates with scholars based in Norway, United States and United Kingdom. Anna Barbro Sætersdal's co-authors include Åslaug Helland, Anne‐Lise Børresen‐Dale, Daniel Nebdal, Anne Trinh, Bent Ejlertsen, Kornélia Polyák, Christian Ingvar, Florian Markowetz, Eva Balslev and Ole Christian Lingjærde and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Radiotherapy and Oncology.

In The Last Decade

Anna Barbro Sætersdal

7 papers receiving 280 citations

Peers

Anna Barbro Sætersdal

ONCOL

CR

MB

PRM

RNMI

Johanna Sjöström Finland

Laura Arthur United Kingdom

Claudette Falato Spain

D. Toppmeyer United States

Berthold Gierke Germany

Wenbo Zheng China

NU Lin United States

Christoph Suppan Austria

Jacqueline Watson United States

J Torhorst Switzerland

Johanna Sjöström Finland

Anna Barbro Sætersdal

227 ×1.2

ONCOL

111 ×0.9

CR

143 ×1.5

MB

52 ×0.9

PRM

25 ×0.6

RNMI

Citations per year, relative to Anna Barbro Sætersdal Anna Barbro Sætersdal (= 1×) peers Johanna Sjöström

Countries citing papers authored by Anna Barbro Sætersdal

Since Specialization

Citations

This map shows the geographic impact of Anna Barbro Sætersdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Barbro Sætersdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Barbro Sætersdal more than expected).

Fields of papers citing papers by Anna Barbro Sætersdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Barbro Sætersdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Barbro Sætersdal. The network helps show where Anna Barbro Sætersdal may publish in the future.

Co-authorship network of co-authors of Anna Barbro Sætersdal

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Barbro Sætersdal. A scholar is included among the top collaborators of Anna Barbro Sætersdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Barbro Sætersdal. Anna Barbro Sætersdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Naume, Bjørn, Steinar Hustad, Ersilia Bifulco, et al.. (2020). Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. Molecular Oncology. 15(4). 957–967. 9 indexed citations

2.

Rye, Inga Hansine, Anne Trinh, Anna Barbro Sætersdal, et al.. (2018). Intratumor heterogeneity defines treatment‐resistant HER 2+ breast tumors. Molecular Oncology. 12(11). 1838–1855. 75 indexed citations

3.

Naume, Bjørn, Marit Synnestvedt, Ragnhild Sørum Falk, et al.. (2014). Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer. Journal of Clinical Oncology. 32(34). 3848–3857. 66 indexed citations

4.

Halvorsen, Ann Rita, Åslaug Helland, Thomas Fleischer, et al.. (2014). Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy. International Journal of Cancer. 135(9). 2085–2095. 28 indexed citations

5.

Ingvar, Christian, Leif Jørgensen, Malgorzata Tuxen, et al.. (2011). Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial. Breast Cancer Research and Treatment. 126(2). 463–470. 73 indexed citations

6.

Helland, Åslaug, Hilde Johnsen, Anna Barbro Sætersdal, et al.. (2006). Radiation-induced effects on gene expression: An in vivo study on breast cancer. Radiotherapy and Oncology. 80(2). 230–235. 17 indexed citations

7.

Sætersdal, Anna Barbro, Anne Dørum, Ketil Heimdal, et al.. (1996). Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at risk.. PubMed. 16(4A). 1989–92. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact